Recombinant Human Gastric Inhibitory Polypeptide

Gastric Inhibitory Polypeptide (GIP) which is a significant insulin-releasing hormone of the enteroinsular axis has a functional profile of possible therapeutic value for type 2 diabetes. GIP is an important incretin hormone released into the circulation from endocrine K-cells of the duodenum and jejunum after ingestion of food1. GIP was evaluated for their ability to elevate cellular cAMP production and stimulate insulin secretion. GIP promotes plasma triglyceride clearance in response to oral fat loading and also enhances insulin-dependent inhibition of glycogenolysis in liver.

E.coli.

The GIP solution (0.25mg/ml) contains 20mM Tris-HCl buffer (pH8.0), 50% glycerol 0.1M NaCl and 2mM DTT.

ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

Store at 4C if entire vial will be used within 2-4 weeks. Store, frozen at -20C for longer periods of time.
For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
Avoid multiple freeze-thaw cycles.